ESR1 and systemic lupus erythematosus: However, selective estrogen receptor modulators raloxifene suppressed estrogen-mediated effects on the survival, differentiation, and activation of autoreactive B cells in NZB/WF1 mice, which might serve to ameliorate lupus activity (Zhang et al., 2010).